BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, SLC12A1, calcium channel activity, Hepatitis, Kidney, Hematopoietic cell)
Bookmark Forward

QuickView for platelet-derived growth factor-activated receptor activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Pericardium
  2. Joint synovium
  3. Ovary
  4. Omental adipose tissue
  5. Vena cava
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Duchenne muscular dystrophy
  2. Disorder affecting transplanted structure
  3. Cytomegalovirus infection
  4. Liver fluke infection
  5. Infection due to Fusobacterium
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid
  2. Buparlisib
  3. CGP 60474
  4. Faslodex
  5. AT 7519
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. CBLL1
  2. PCDH11X
  3. FN1
  4. ELF5
  5. NAPEPLD
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Skin biopsies from psoriasis patients treated with adalimumab or methotrexate
  2. OCT4 over-expression and knockdown in mammary epithelial (HMEC) breast cells
  3. L1000 CMAP - Pancreatic cancer YAPC.311 cells with CRISPR-targeted gene knockouts
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  5. Luminal, basal, and stromal cell subtypes from normal reduction mammoplasties
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in…
  2. Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. LPS and Platelet Activation in Myocardial Infarction
  2. Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacet…
  3. Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor R…
  4. Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lu…
  5. A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.